Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2001, p. 2054-2059, Vol. 45, No. 7
Danish Veterinary Laboratory, DK-1790
Copenhagen V1 and DK-8200 Aarhus
N,2 Denmark
Received 28 July 2000/Returned for modification 27 November
2000/Accepted 16 April 2001
From 1995 to 2000, a total of 673 Enterococcus faecium
and 1,088 Enterococcus faecalis isolates from pigs together
with 856 E. faecium isolates from broilers were isolated
and tested for susceptibility to four classes of antimicrobial agents
used for growth promotion as part of the Danish program of monitoring
for antimicrobial resistance. The four antimicrobials were avilamycin, erythromycin, vancomycin, and virginiamycin. Major changes in the use
of antimicrobial agents for growth promotion have occurred during the
last 6 years in Denmark. The government banned the use of avoparcin in
1995 and of virginiamycin in 1998. Furthermore, the producers have
voluntarily stopped all use beginning in 1999. The avoparcin ban in
1995 was followed by a decrease in the occurrence of
glycopeptide-resistant E. faecium (GRE) in broilers, from
72.7% in 1995 to 5.8% in 2000. The occurrence of glycopeptide
resistance among isolates from pigs remained constant at around 20%
from 1995 to 1997. It was shown that, in GRE from pigs, the genes
encoding macrolide and glycopeptide resistance were genetically linked and that, following the decrease in the use of tylosin during 1998 and
1999, the occurrence of GRE in pigs decreased to 6.0% in 2000. From
1995 to 1997 the occurrence of erythromycin resistance among E. faecium and E. faecalis isolates from pigs was almost 90%. Use of tylosin decreased considerably during 1998 and 1999, and
this decrease was followed by decreases in the occurrence of resistance
to 46.7 and 28.1% among E. faecium and E. faecalis isolates from pigs, respectively. Erythromycin
resistance among E. faecium isolates from broilers reached
a maximum of 76.3% in 1997 but decreased to 12.7% in 2000 concomitantly with more limited use of virginiamycin. Use of
virginiamycin increased from 1995 to 1997 and was followed by an
increased occurrence of virginiamycin resistance among E. faecium isolates in broilers, from 27.3% in 1995 to 66.2% in
1997. In January 1998 the use of virginiamycin was banned in Denmark,
and the occurrence of virginiamycin resistance decreased to 33.9% in
2000. Use of avilamycin increased from 1995 to 1996 and was followed by
an increase in avilamycin resistance among E. faecium
isolates from broilers, from 63.6% in 1995 to 77.4% in 1996. Since
1996 avilamycin usage has decreased, followed by a decrease in
resistance to 4.8% in 2000. Our observations show that it is possible
to reduce the occurrence of antimicrobial resistance in a national
population of food animals when the selective pressure is removed.
Cases in which resistance to vancomycin was linked to resistance to
erythromycin were exceptions. In such cases resistance did not decrease
until the use of both avoparcin and tylosin was limited.
No acquired resistance genes were
demonstrated for bacteria isolated from patients more than 60 years ago
(18), but emergence of antimicrobial resistance has
invariably followed the introduction of new antimicrobial compounds
(25). Multiply resistant pathogenic bacteria have
emerged worldwide during the last couple of decades, and multiple
antimicrobial resistance is now one of the serious concerns of the new
millennium (15, 23, 28). In particular the worldwide
emergence of glycopeptide-resistant enterococci and the increase in
their occurrence, pose a serious threat to the continued possibility of
curing infections in humans (12, 14, 22, 31; D. F. Sahm, Program
Abstr. 1st Int. ASM Conf. Enterococci, abstr. addendum, 2000). It is
unlikely that new antimicrobial agents can be developed at a rate to
adequately combat the increasing number of multiresistant bacteria.
As early as the 1960s, concern over the emergence of resistant bacteria
in domestic animals led the Swann Committee (32) to
recommend that antimicrobials that were of value for treatment of
humans should not be approved for growth promotion in food animals.
These guidelines have since been implemented in most European
countries. However, the guidelines did not take into account
antimicrobials that were of little or no significance in human medicine
at the time when they were approved for growth promotion in food
animals. Because of the emergence of multiply resistant bacteria
causing infections in humans, some of these classes of antimicrobials
have become important last resort drugs in the treatment of such
infections. Examples include avoparcin, virginiamycin, and
avilamycin, which belong to the same classes as the human drugs
vancomycin, quinupristin-dalfopristin (Synercid), and evernimicin
(Ziracin), respectively. In 2000 the manufacturer of Ziracin suspended
its development. European Union rules for approval of feed additives
have recently been amended; they now require application for reapproval
of all such additives, including antimicrobials used for growth
promotion, at fixed intervals.
It has been demonstrated that food animals may serve as a reservoir of
resistant bacteria and/or resistance genes that may spread to the human
population and thereby limit the medical value of these new
antimicrobial classes (1, 3, 36). Thus, interventions reducing this reservoir of resistance genes among food animals may
prolong the lifetime of these drugs for human use. For these reasons
international public health organizations such as the World Health
Organization have recommended the termination or rapid phasing out of
the use of antimicrobial growth promoters (AGPs) that are also used for
therapy or are under development for therapy (37).
Since 1995, major changes in the consumption of antimicrobial agents
used for growth promotion have occurred in Denmark. Avoparcin was
banned in May 1995, and virginiamycin was banned in January 1998. Furthermore, the food animal industries decided in 1998 to voluntarily
stop all use of antimicrobial agents for growth promotion by the end of
1999. These steps were taken as precautionary measures, to prevent
future problems with antimicrobial resistance in human medicine. The
ban and voluntary withdrawal were based on the expectation that removal
of the selective antimicrobial pressure in animals would reduce the
exposure of humans, via food, to resistant bacteria from animals.
Several studies have shown that the occurrence of resistance is closely
related to the medical use of a drug, even though the association may
be variable (11, 15, 26). This association has also been
demonstrated for antimicrobial agents used for growth promotion
(4, 6, 9). In contrast, little information is available
about the effects of terminating the use of an antimicrobial agent on
the occurrence of antimicrobial resistance in large human or animal
populations outside hospitals.
Danish food animal production is highly industrialized and well
monitored, with the main emphasis on a few categories, such as porkers,
broilers, layers, and milk cows, and with limited variation in animal
breeds and production methods within each production category.
Therefore, it provides a homogenous population suitable for studying
changes in bacterial populations living in these reservoirs. A
continuous national monitoring program for antimicrobial resistance was
established in 1995 (7). This program monitors, for
example, the occurrence of resistance among enterococci isolated from
healthy animals at slaughter and thereby gives an overview of the
general trend of resistance in food animals.
In this study, changes in the occurrence of resistance to
glycopeptides, macrolides, oligosaccharides, and streptogramins that
have taken place following termination of the use of these antimicrobial agents for growth promotion are reported.
Details of the sampling scheme and of the isolation,
identification, and susceptibility testing of enterococci from broilers and pigs have been published previously (5, 10).
Collection of samples.
All isolates were recovered from
cecal samples (pigs) or cloacal swabs (broilers) from healthy animals,
and only a single isolate per pig herd or broiler flock was included.
The number of samples collected monthly from pigs and weekly from
broilers from each slaughterhouse was proportional to the annual number of animals slaughtered. This ensures, as far as possible, that samples
are representative of the entire country and that each sample
represents a herd or flock.
Isolation, identification, and susceptibility testing.
For
broilers, cloacal swabs were enriched in enterococcal broth (Becton
Dickinson) overnight at 42°C, followed by subcultivation on Slanetz
and Bartley agar (Difco) at 37°C for 18 to 24 h. Cecal samples
from pigs were streaked directly onto Slanetz and Bartley agar.
Isolates resembling enterococci were subcultured and identified biochemically as Enterococcus faecalis and
Enterococcus faecium (5). During 1995 and 1996, susceptibility testing for erythromycin, vancomycin, and virginiamycin
was performed by tablet diffusion (5). From 1997 onwards
all susceptibility testing was done by determining the MIC using
microwell broth dilution (Sensititre; Trek Diagnostic Systems) in
Mueller Hinton broth (Difco) according to NCCLS guidelines
(27). All susceptibility testing for avilamycin from 1995 to 2000 was performed by determining MICs using agar dilution as
previously described (5). In categorizing the results the
following breakpoints (5, 27) for resistance were used: for avilamycin, Data handling.
Test results were stored in an Oracle,
version 7.14, database. Data processing and evaluation were carried out
in PC SAS, versions 6.12 and 8.0, and EpiInfo, version 6.02. The 95%
confidence interval for the estimated percent resistance was calculated
by using a SAS macro according to the work of Blyth (13).
Use of antimicrobial agents for growth promotion.
Manufacturers licensed to produce premixes are obliged to collect data
on the use of antimicrobials for growth promotion. These data are
requested by The Danish Plant Directorate and published annually.
Avilamycin, avoparcin, and virginiamycin have never been used for
therapy. Data on the use of antimicrobial agents for therapy are
collected by the Danish Medicine Agency. All data are published
annually in the Danish Integrated Antimicrobial Resistance Monitoring
and Research Programme (DANMAP) report (8). The use of
antimicrobial agents for growth promotion in Denmark from 1994 through
2000 is shown in Table 1. The level of use of macrolides and
lincosamides for treatment of production animals has been 7 to 8 tons
annually in the period 1995 through 1999. Because antimicrobials for
food animals are freely available Size of the animal population.
Statistics on the production
of broilers, cattle, and pigs in Denmark are published annually by
Danmarks Statistik (16). The levels of production from
1995 through 1999 are given in Table 2.
The use of antimicrobial agents for growth promotion
decreased drastically from 1995 to 2000 (Table
1). In the same period the production of
food animals remained constant or even increased (Table
2). Thus, the decreased usage of AGPs
does not correlate with major changes in food animal production.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2054-2059.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Effect of Abolishment of the Use of Antimicrobial Agents for
Growth Promotion on Occurrence of Antimicrobial Resistance in
Fecal Enterococci from Food Animals in Denmark
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
16 µg/ml; for erythromycin, 8 µg/ml; for
vancomycin, 32 µg/ml; and for virginiamycin, 8 µg/ml.
although therapeutics are available
only by prescriptionand are competitively priced compared with other
European countries, it is generally considered that there is no black
market, or only a negligible one, for antimicrobials in food animals.
Therefore, the official figures closely represent actual consumption.
RESULTS AND DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
TABLE 1.
Use of AGPs in Denmark from 1994 through
2000a
TABLE 2.
Production of food animals in Denmark from 1995 through 1999a
The monitoring of antimicrobial resistance among food animals in Denmark is based on randomly selected bacterial isolates. The sampling strategy used will detect only the most prevalent flora. Thus, resistance may be present at a low level and not be detected by the monitoring system. However, the results can be compared over time and will show changes in the occurrence of resistance.
From 1995 to 2000, a total of 673 E. faecium and 1,088 E. faecalis isolates from pigs, together with 856 E. faecium isolates from broilers, were isolated and tested
for antimicrobial susceptibility. The trends in the occurrence of
resistance over time and the 95% confidence intervals are given in
Table 3. Different numbers of isolates
were examined in different years, and during 1995 only a very limited
number of isolates were included. This gives very wide 95% confidence
intervals for the 1995 results (Table 3).
|
Over the entire period only four (0.6%) E. faecium isolates from pigs were resistant to avilamycin. E. faecalis isolates have naturally decreased susceptibility to streptogramin, and thus no results for virginiamycin are given. All E. faecalis isolates were susceptible to vancomycin, and 21 (1.9%) of the isolates from pigs were resistant to avilamycin.
Resistance to antimicrobial agents used for growth promotion was more
common in E. faecium than in E. faecalis. The
only exception was macrolide resistance, where similar levels were
observed. The trends in resistance and the consumption of
antimicrobials as growth promoters from 1995 to 2000 are presented in
Fig. 1.
|
The total level of consumption of each of the antimicrobial agents used for growth promotion in Denmark is well known, but it is very difficult to obtain exact data on the consumption of antimicrobial agents for growth promotion for the different food animal species. However, the macrolide tylosin is approved only for pigs, and avilamycin has been used primarily for broilers. After the ban on avoparcin in 1995, increased use of tylosin for pigs and of virginiamycin for broilers mainly replaced the use of avoparcin.
The avoparcin ban in 1995 was almost immediately followed by a decrease in the occurrence of glycopeptide-resistant E. faecium (GRE) in broilers (Table 3; Fig. 1). In 1995 72.7% of the isolates were resistant to vancomycin; this decreased to 5.8% in 2000. However, the occurrence of resistance among isolates from pigs remained relatively constant at around 20% during 1995 through 1996. It was shown that all GRE isolates from pigs belonged to the same clone and that genes encoding resistance to glycopeptides and macrolides were located close to each other on the same plasmid (2). Therefore, GRE in pigs may well have been maintained as a consequence of coselection by use of the macrolide tylosin. Indeed, following the decrease in the use of tylosin during 1998 and 1999, the occurrence of GRE in pigs decreased significantly to 6.0% in 2000 (Fig. 1). Nonetheless, almost 6 years after the ban of avoparcin, resistant E. faecium can still be found among broilers and pigs in Denmark, showing that it can take a very long time for resistance to disappear.
For several years the macrolide tylosin was the most widely used AGP for pigs in Denmark. In 1995 the occurrence of resistance among E. faecium isolates from pigs was 80.0%, in 1996 it was 93.1%, and in 1997 it was 87.3%. Among E. faecalis isolates resistance was 93.9% in 1995, 90.7% in 1996, and 91.1% in 1997. The use of tylosin decreased considerably during 1998 and 1999. This was almost immediately followed by a decrease in the occurrence of resistance among both E. faecium and E. faecalis isolates from pigs (Table 3; Fig. 1). Thus, in 1998 resistance among E. faecium isolates had decreased to 70.6%, and that among E. faecalis isolates had decreased to 78.7%. Resistance decreased further, to 47.8 and 48.0%, respectively, in 1999 and to 46.7 and 28.1%, respectively, in 2000. Macrolides are still widely used for treatment of infections in pigs, and thus future trends in the occurrence of resistance cannot yet be predicted.
The occurrence of macrolide resistance among E. faecium isolates from broilers has also been very high, reaching a maximum of 76.3% in 1997. It decreased to 27.5% during 1999 and to 12.7% during 2000, concomitantly with the more-limited use of virginiamycin (Tables 1 and 3; Fig. 1). Relatively minor amounts of the macrolide spiramycin have been used for growth promotion in broilers. However, virginiamycin is a natural combination of two structurally unrelated molecules (groups A and B) (30), and group B has the same mechanism of action as antimicrobials belonging to the macrolides (34). Enzymes methylating the target site of macrolides, lincosamides, and streptogramin B have been observed to be the most common cause of resistance in enterococci (19, 21). In addition, it has recently been shown that some of the genes encoding resistance to group A and group B, respectively, are genetically linked (20, 35). Thus, it seems likely that the use of virginiamycin as a growth promoter for broilers may have selected for macrolide resistance in E. faecium.
The use of virginiamycin increased between 1995 to 1997. The increase was seen mainly in broilers and was associated with an increase in the occurrence of resistance in E. faecium. Thus, virginiamycin resistance among E. faecium isolates from broilers increased from 27.3% in 1995 to 66.2% in 1997. In January 1998, the use of virginiamycin was banned in Denmark, and the occurrence of resistance subsequently decreased to 33.9% in 2000 (Fig. 1). More variation in the occurrence of virginiamycin resistance can be observed among E. faecium isolates from pigs. Thus, resistance decreased from 60.0% in 1995 to 36.4% in 1997, increased in 1998 to 55.6%, decreased again in 1999 to 8.0%, and increased again in 2000 to 22.5% (Table 3). The reason for this variation is not known. However, the increase in resistance during 2000 is mainly due to the emergence of isolates that are simultaneously resistant to erythromycin, kanamycin, penicillin, streptomycin, tetracycline, and virginiamycin (data not shown). These isolates will now be investigated further.
In Denmark, avilamycin has been used primarily for broilers. Use of this oligosaccharide increased from 1995 to 1996, followed by an increase in resistance among E. faecium isolates from 63.6% in 1995 to 77.4% in 1996. Since 1996, the level of use has decreased, almost immediately followed by a decrease in resistance to 4.8% in 2000 (Fig. 1).
The effects of the ban of growth promoters for food animals on the occurrence of antimicrobial resistance among humans have not been determined. However, the GRE carrier rate among healthy humans in Germany decreased from 13% in 1994 to 4% in 1997 (24) following the German ban on avoparcin in 1996. Similarly, a decrease in the occurrence of GRE has been observed among poultry products in Italy during the 18 months following the ban of avoparcin (29) and among humans, broilers, and pigs in The Netherlands from 1997 to 1999 (33) following the ban here.
Our observations show that it is possible to reduce the occurrence of antimicrobial resistance in a national population of food animals when the selective pressure is removed. However, we have also demonstrated that under certain conditions resistance may persist, most likely as a consequence of coselection. It is not possible to foresee whether the occurrence of resistance will decrease to an undetectable level in the future. Vancomycin-resistant E. faecium can still be found among broilers and pigs in Denmark more than 5 years after the ban of avoparcin. In the future, resistant isolates may still persist in low numbers that are not detected by the monitoring methods used. In the case of antimicrobials used in animal production, it is of great importance to prevent increases in the resistance gene reservoir to the extent possible, in particular for agents belonging to classes that are or may become important in human medicine.
The results discussed above represent the first documented effects of large-scale interventions to reduce the occurrence of antimicrobial resistance. They demonstrate that the exposure of humans to bacteria resistant to antimicrobial drugs and to resistance genes through food can be reduced effectively by intervention.
| |
ACKNOWLEDGMENTS |
|---|
We thank the laboratory technicians of the antimicrobial resistance group for their assistance and Henrik Stryhn to for constructing the SAS macro used for determining the confidence intervals.
This study was part of DANMAP, conducted in collaboration between the Statens Serum Institut, the National Food Agency of Denmark, and the Danish Veterinary Laboratory and funded jointly by the Danish Ministry of Health and the Danish Ministry of Food, Agriculture, and Fisheries.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Danish Veterinary Laboratory, 27 Bülowsvej, DK-1790 Copenhagen V, Denmark. Phone: 45 35 30 01 00. Fax: 45 35 30 01 20. E-mail: faa{at}svs.dk.
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References
|
|---|
| 1. | Aarestrup, F. M. 1999. Association between the consumption of antimicrobial agents in animal husbandry and the occurrence of resistant bacteria among food animals. Int. J. Antimicrob. Agents 12:279-285[CrossRef][Medline]. |
| 2. |
Aarestrup, F. M.
2000.
Characterization of glycopeptide-resistant Enterococcus faecium (GRE), from broilers and pigs in Denmark: genetic evidence that persistence of GRE in pig herds is associated with coselection by resistance to macrolides.
J. Clin. Microbiol.
38:2774-2777 |
| 3. | Aarestrup, F. M. 2000. Occurrence, selection and spread of resistance to antimicrobial agents used for growth promotion in Denmark. APMIS 108(Suppl. 101):3-48. |
| 4. | Aarestrup, F. M., and B. Carstensen. 1998. Effect of tylosin used as a growth promoter on the occurrence of macrolide resistant enterococci and staphylococci in pigs. Microb. Drug Resist. 4:307-312[Medline]. |
| 5. | Aarestrup, F. M., F. Bager, N. E. Jensen, M. Madsen, A. Meyling, and H. C. Wegener. 1998. Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark. APMIS 106:606-622[Medline]. |
| 6. | Aarestrup, F. M., F. Bager, and J. S. Andersen. 2000. The association between the use of avilamycin for growth promotion and the occurrence of resistance among Enterococcus faecium. Microb. Drug Resist. 6:71-76[Medline]. |
| 7. | Anonymous. 1998. The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme (DANMAP). APMIS 106:605[Medline]. |
| 8. | Anonymous. 2000. Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. DANMAP 99 Copenhagen, Denmark. |
| 9. | Bager, F., M. Madsen, J. Christensen, and F. M. Aarestrup. 1997. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev. Vet. Med. 31:95-112[CrossRef][Medline]. |
| 10. | Bager, F., F. M. Aarestrup, M. Madsen, and H. C. Wegener. 1999. Glycopeptide resistance in Enterococcus faecium from broilers and pigs following discontinued use of avoparcin. Microb. Drug Resist. 5:53-56[Medline]. |
| 11. | Baquero, F., J. Martinez-Beltran, and E. Loza. 1991. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J. Antimicrob. Chemother. 28(Suppl. C):31-83. |
| 12. |
Bell, J. M.,
J. C. Paton, and J. Turnigde.
1998.
Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates.
J. Clin. Microbiol.
36:2187-2190 |
| 13. | Blyth, C. R. 1986. Approximate binomial confidence limits. J. Am. Statist. Assoc. 81:843-855[CrossRef]. |
| 14. | Budavari, S. M., G. L. Saunders, L. D. Liebowitz, M. Khoosal, and H. H. Crewe-Brown. 1997. Emergence of vancomycin-resistant enterococci in South Africa. S. Afr. Med. J. 87:1557[Medline]. |
| 15. | Ciba Foundation. 1997. Antibiotic resistance: origins, evolution, selection and spread. Wiley and Sons, Chichester, United Kingdom. |
| 16. | Danmarks Statistik. 2000. Statistical yearbook 2000: agricultural statistics. Danmarks, Statistik, Copenhagen, Denmark. |
| 17. | Hsueh, P. R., L. J. Teng, H. J. Pan, Y. C. Chen, L. H. Wang, S. C. Chang, S. W. Ho, and K. T. Luh. 1999. Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: persistence of multiple species and multiple clones. Infect. Control Hosp. Epidemiol. 20:828-833[CrossRef][Medline]. |
| 18. | Hughes, V. M., and N. Datta. 1983. Conjugative plasmids in bacteria of the `pre-antibiotic' era. Nature 302:725-726[CrossRef][Medline]. |
| 19. | Jensen, L. B., N. Frimodt-Moller, and F. M. Aarestrup. 1999. Presence of erm gene classes in gram-positive bacteria of animal and human origin in Denmark. FEMS Microbiol. Lett. 170:151-158[CrossRef][Medline]. |
| 20. |
Jensen, L. B.,
A. M. Hammerum, and F. M. Aarestrup.
2000.
Linkage of vatE and ermB in streptogramin-resistant Enterococcus faecium isolates from Europe.
Antimicrob. Agents Chemother.
44:2231-2232 |
| 21. |
Jenssen, W. D.,
S. Thakker-Varia,
D. T. Dubin, and M. P. Weinstein.
1987.
Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci.
Antimicrob. Agents Chemother.
31:883-888 |
| 22. |
Johnson, A. P.,
M. Warner,
N. Woodford,
D. C. Speller, and D. M. Livermore.
1998.
Antibiotic resistance among enterococci causing endocarditis in the UK: analysis of isolates referred to a reference laboratory.
BMJ
317:629-630 |
| 23. | Jones, R. N., and M. A. Pfaller. 1998. Bacterial resistance: a worldwide problem. Diagn. Microbiol. Infect. Dis. 31:379-388[CrossRef][Medline]. |
| 24. | Klare, I., D. Badstubner, C. Konstabel, G. Bohme, H. Claus, and W. Witte. 1999. Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb. Drug Resist. 5:45-52[Medline]. |
| 25. | Levy, S. B. 1982. Microbial resistance to antibiotics. An evolving and persistent problem. Lancet ii:83-88. |
| 26. |
Mouton, R. P.,
J. Hermans,
A. M. Simoons-Smit,
J. A. Hoogkamp-Korstanje,
J. E. Degener, and B. van Klingeren.
1990.
Correlations between consumption of antibiotics and methicillin resistance in coagulase-negative staphylococci.
J. Antimicrob. Chemother.
26:573-583 |
| 27. | National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa. |
| 28. | Neu, H. C. 1992. The crisis in antibiotic resistance. Science 257:1064. |
| 29. | Pantosti, A., M. Del Grosso, S. Tagliabue, A. Macri, and A. Caprioli. 1999. Decrease of vancomycin-resistant enterococci in poultry meat after avoparcin ban. Lancet 354:741-742[CrossRef][Medline]. |
| 30. | Pechére, J.-C. 1996. Streptogramins: a unique class of antibiotics. Drugs 51(Suppl. 1):13-19. |
| 31. |
Schouten, M. A.,
A. Voss, and J. A. Hoogkamp-Korstanje.
1999.
Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group.
Antimicrob. Agents Chemother.
43:2542-2546 |
| 32. | Swann, M. M. 1969. Joint Committee on the use of Antibiotics in Animal Husbandry and Veterinary Medicine. Her Majesty's Stationery Office, London, United Kingdom. |
| 33. |
van den Bogaard, A. E.,
N. Bruinsma, and E. E. Stobberingh.
2000.
The effect of banning avoparcin on VRE carriage in The Netherlands.
J. Antimicrob. Chemother.
46:146-147 |
| 34. | Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39:577-585[Medline]. |
| 35. | Werner, G., B. Hildebrandt, I. Klare, and W. Witte. 2000. Linkage of determinants for streptogramin A, macrolide-lincosamide-streptogramin B, and chloramphenicol resistance on a conjugative plasmid in Enterococcus faecium and dissemination of this cluster among streptogramin-resistant enterococci. Int. J. Med. Microbiol. 290:543-548[Medline]. |
| 36. |
Witte, W.
1998.
Medical consequences of antibiotic use in agriculture.
Science
279:996-997 |
| 37. | World Health Organization. 2000. WHO global principles for the containment of antimicrobial resistance in animals intended for food. Report of a WHO consultation. World Health Organization, Geneva, Switzerland. |
Antimicrobial Agents and Chemotherapy, July 2001, p. 2054-2059, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2054-2059.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rezzonico, F., Stockwell, V. O., Duffy, B.
(2009). Plant Agricultural Streptomycin Formulations Do Not Carry Antibiotic Resistance Genes. Antimicrob. Agents Chemother.
53: 3173-3177
[Abstract] [Full Text] -
Nilsson, O., Greko, C., Top, J., Franklin, A., Bengtsson, B.
(2009). Spread without known selective pressure of a vancomycin-resistant clone of Enterococcus faecium among broilers. J Antimicrob Chemother
63: 868-872
[Abstract] [Full Text] -
Mariano, V., McCrindle, C. M. E., Cenci-Goga, B., Picard, J. A.
(2009). Case-Control Study To Determine whether River Water Can Spread Tetracycline Resistance to Unexposed Impala (Aepyceros melampus) in Kruger National Park (South Africa). Appl. Environ. Microbiol.
75: 113-118
[Abstract] [Full Text] -
Kaneene, J. B., Warnick, L. D., Bolin, C. A., Erskine, R. J., May, K., Miller, R.
(2008). Changes in Tetracycline Susceptibility of Enteric Bacteria following Switching to Nonmedicated Milk Replacer for Dairy Calves. J. Clin. Microbiol.
46: 1968-1977
[Abstract] [Full Text] -
Jacob, M. E., Fox, J. T., Narayanan, S. K., Drouillard, J. S., Renter, D. G., Nagaraja, T. G.
(2008). Effects of feeding wet corn distillers grains with solubles with or without monensin and tylosin on the prevalence and antimicrobial susceptibilities of fecal foodborne pathogenic and commensal bacteria in feedlot cattle. J ANIM SCI
86: 1182-1190
[Abstract] [Full Text] -
Macovei, L., Zurek, L.
(2007). Influx of Enterococci and Associated Antibiotic Resistance and Virulence Genes from Ready-To-Eat Food to the Human Digestive Tract. Appl. Environ. Microbiol.
73: 6740-6747
[Abstract] [Full Text] -
Garcia-Migura, L., Liebana, E., Jensen, L. B.
(2007). Transposon characterization of vancomycin-resistant Enterococcus faecium (VREF) and dissemination of resistance associated with transferable plasmids. J Antimicrob Chemother
60: 263-268
[Abstract] [Full Text] -
Niewold, T. A.
(2007). The Nonantibiotic Anti-Inflammatory Effect of Antimicrobial Growth Promoters, the Real Mode of Action? A Hypothesis. Poult. Sci.
86: 605-609
[Abstract] [Full Text] -
Donabedian, S. M., Perri, M. B., Vager, D., Hershberger, E., Malani, P., Simjee, S., Chow, J., Vergis, E. N., Muder, R. R., Gay, K., Angulo, F. J., Bartlett, P., Zervos, M. J.
(2006). Quinupristin-Dalfopristin Resistance in Enterococcus faecium Isolates from Humans, Farm Animals, and Grocery Store Meat in the United States.. J. Clin. Microbiol.
44: 3361-3365
[Abstract] [Full Text] -
Raymond, M. J., Wohrle, R. D., Call, D. R.
(2006). Assessment and promotion of judicious antibiotic use on dairy farms in Washington State.. J DAIRY SCI
89: 3228-3240
[Abstract] [Full Text] -
Khachatryan, A. R., Besser, T. E., Hancock, D. D., Call, D. R.
(2006). Use of a Nonmedicated Dietary Supplement Correlates with Increased Prevalence of Streptomycin-Sulfa-Tetracycline-Resistant Escherichia coli on a Dairy Farm.. Appl. Environ. Microbiol.
72: 4583-4588
[Abstract] [Full Text] -
Macovei, L., Zurek, L.
(2006). Ecology of antibiotic resistance genes: characterization of enterococci from houseflies collected in food settings.. Appl. Environ. Microbiol.
72: 4028-4035
[Abstract] [Full Text] -
Batista Xavier, D., Moreno Bernal, F. E., Titze-de-Almeida, R.
(2006). Absence of VanA- and VanB-Containing Enterococci in Poultry Raised on Nonintensive Production Farms in Brazil. Appl. Environ. Microbiol.
72: 3072-3073
[Abstract] [Full Text] -
Khachatryan, A. R., Hancock, D. D., Besser, T. E., Call, D. R.
(2006). Antimicrobial Drug Resistance Genes Do Not Convey a Secondary Fitness Advantage to Calf-Adapted Escherichia coli. Appl. Environ. Microbiol.
72: 443-448
[Abstract] [Full Text] -
Sorum, M., Johnsen, P. J., Aasnes, B., Rosvoll, T., Kruse, H., Sundsfjord, A., Simonsen, G. S.
(2006). Prevalence, Persistence, and Molecular Characterization of Glycopeptide-Resistant Enterococci in Norwegian Poultry and Poultry Farmers 3 to 8 Years after the Ban on Avoparcin. Appl. Environ. Microbiol.
72: 516-521
[Abstract] [Full Text] -
Poole, T. L., Callaway, T. R., Bischoff, K. M., Warnes, C. E., Nisbet, D. J.
(2006). Macrolide inactivation gene cluster mphA-mrx-mphR adjacent to a class 1 integron in Aeromonas hydrophila isolated from a diarrhoeic pig in Oklahoma. J Antimicrob Chemother
57: 31-38
[Abstract] [Full Text] -
Fairchild, A. S., Smith, J. L., Idris, U., Lu, J., Sanchez, S., Purvis, L. B., Hofacre, C., Lee, M. D.
(2005). Effects of Orally Administered Tetracycline on the Intestinal Community Structure of Chickens and on tet Determinant Carriage by Commensal Bacteria and Campylobacter jejuni. Appl. Environ. Microbiol.
71: 5865-5872
[Abstract] [Full Text] -
Garcia-Migura, L., Pleydell, E., Barnes, S., Davies, R. H., Liebana, E.
(2005). Characterization of Vancomycin-Resistant Enterococcus faecium Isolates from Broiler Poultry and Pig Farms in England and Wales. J. Clin. Microbiol.
43: 3283-3289
[Abstract] [Full Text] -
Petsaris, O., Miszczak, F., Gicquel-Bruneau, M., Perrin-Guyomard, A., Humbert, F., Sanders, P., Leclercq, R.
(2005). Combined Antimicrobial Resistance in Enterococcus faecium Isolated from Chickens. Appl. Environ. Microbiol.
71: 2796-2799
[Abstract] [Full Text] -
Stampone, L., Del Grosso, M., Boccia, D., Pantosti, A.
(2005). Clonal Spread of a Vancomycin-Resistant Enterococcus faecium Strain among Bloodstream-Infecting Isolates in Italy. J. Clin. Microbiol.
43: 1575-1580
[Abstract] [Full Text] -
Smith, D. L., Levin, S. A., Laxminarayan, R.
(2005). From The Cover: Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proc. Natl. Acad. Sci. USA
102: 3153-3158
[Abstract] [Full Text] -
Hasman, H., Aarestrup, F. M.
(2005). Relationship between Copper, Glycopeptide, and Macrolide Resistance among Enterococcus faecium Strains Isolated from Pigs in Denmark between 1997 and 2003. Antimicrob. Agents Chemother.
49: 454-456
[Abstract] [Full Text] -
Johnsen, P. J., Osterhus, J. I., Sletvold, H., Sorum, M., Kruse, H., Nielsen, K., Simonsen, G. S., Sundsfjord, A.
(2005). Persistence of Animal and Human Glycopeptide-Resistant Enterococci on Two Norwegian Poultry Farms Formerly Exposed to Avoparcin Is Associated with a Widespread Plasmid-Mediated vanA Element within a Polyclonal Enterococcus faecium Population. Appl. Environ. Microbiol.
71: 159-168
[Abstract] [Full Text] -
Manson, J. M., Smith, J. M. B., Cook, G. M.
(2004). Persistence of Vancomycin-Resistant Enterococci in New Zealand Broilers after Discontinuation of Avoparcin Use. Appl. Environ. Microbiol.
70: 5764-5768
[Abstract] [Full Text] -
Hayes, J. R., English, L. L., Carr, L. E., Wagner, D. D., Joseph, S. W.
(2004). Multiple-Antibiotic Resistance of Enterococcus spp. Isolated from Commercial Poultry Production Environments. Appl. Environ. Microbiol.
70: 6005-6011
[Abstract] [Full Text] -
Kummerer, K.
(2004). Resistance in the environment. J Antimicrob Chemother
54: 311-320
[Abstract] [Full Text] -
Jackson, C. R., Fedorka-Cray, P. J., Barrett, J. B., Ladely, S. R.
(2004). Effects of Tylosin Use on Erythromycin Resistance in Enterococci Isolated from Swine. Appl. Environ. Microbiol.
70: 4205-4210
[Abstract] [Full Text] -
Bryan, A., Shapir, N., Sadowsky, M. J.
(2004). Frequency and Distribution of Tetracycline Resistance Genes in Genetically Diverse, Nonselected, and Nonclinical Escherichia coli Strains Isolated from Diverse Human and Animal Sources. Appl. Environ. Microbiol.
70: 2503-2507
[Abstract] [Full Text] -
Jones, R. N., Deshpande, L. M.
(2004). Are Enterococcus faecalis Strains with vat(E) in Poultry a Reservoir for Human Streptogramin Resistance? vat(E) Occurrence in Human Enterococcal Bloodstream Infections in North America (SENTRY Antimicrobial Surveillance Program, 2002). Antimicrob. Agents Chemother.
48: 360-361
[Full Text] -
Phillips, I., Casewell, M., Cox, T., De Groot, B., Friis, C., Jones, R., Nightingale, C., Preston, R., Waddell, J.
(2004). Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J Antimicrob Chemother
53: 28-52
[Abstract] [Full Text] -
Hayes, J. R., English, L. L., Carter, P. J., Proescholdt, T., Lee, K. Y., Wagner, D. D., White, D. G.
(2003). Prevalence and Antimicrobial Resistance of Enterococcus Species Isolated from Retail Meats. Appl. Environ. Microbiol.
69: 7153-7160
[Abstract] [Full Text] -
Solway, S., Vincent, L., Tian, N., Woodford, N., Bendall, R.
(2003). Isolation of streptogramin-resistant Enterococcus faecium from human and non-human sources in a rural community. J Antimicrob Chemother
52: 707-710
[Abstract] [Full Text] -
Manson, J. M., Keis, S., Smith, J. M. B., Cook, G. M.
(2003). A Clonal Lineage of VanA-Type Enterococcus faecalis Predominates in Vancomycin-Resistant Enterococci Isolated in New Zealand. Antimicrob. Agents Chemother.
47: 204-210
[Abstract] [Full Text] -
Simjee, S., White, D. G., Wagner, D. D., Meng, J., Qaiyumi, S., Zhao, S., McDermott, P. F.
(2002). Identification of vat(E) in Enterococcus faecalis Isolates from Retail Poultry and Its Transferability to Enterococcus faecium. Antimicrob. Agents Chemother.
46: 3823-3828
[Abstract] [Full Text] -
Simjee, S., White, D. G., Meng, J., Wagner, D. D., Qaiyumi, S., Zhao, S., Hayes, J. R., McDermott, P. F.
(2002). Prevalence of streptogramin resistance genes among Enterococcus isolates recovered from retail meats in the Greater Washington DC area. J Antimicrob Chemother
50: 877-882
[Abstract] [Full Text] -
Kofoed, C. B., Vester, B.
(2002). Interaction of Avilamycin with Ribosomes and Resistance Caused by Mutations in 23S rRNA. Antimicrob. Agents Chemother.
46: 3339-3342
[Abstract] [Full Text] -
Aarestrup, F. M., McNicholas, P. M.
(2002). Incidence of High-Level Evernimicin Resistance in Enterococcus faecium among Food Animals and Humans. Antimicrob. Agents Chemother.
46: 3088-3090
[Abstract] [Full Text] -
Aarestrup, F. M., Hasman, H., Jensen, L. B., Moreno, M., Herrero, I. A., Dominguez, L., Finn, M., Franklin, A.
(2002). Antimicrobial Resistance among Enterococci from Pigs in Three European Countries. Appl. Environ. Microbiol.
68: 4127-4129
[Abstract] [Full Text] -
Gentilini, E., Denamiel, G., Betancor, A., Rebuelto, M., Fermepin, M. R., De Torres, R. A.
(2002). Antimicrobial Susceptibility of Coagulase-Negative Staphylococci Isolated from Bovine Mastitis in Argentina. J DAIRY SCI
85: 1913-1917
[Abstract] [Full Text] -
Hasman, H., Aarestrup, F. M.
(2002). tcrB, a Gene Conferring Transferable Copper Resistance in Enterococcus faecium: Occurrence, Transferability, and Linkage to Macrolide and Glycopeptide Resistance. Antimicrob. Agents Chemother.
46: 1410-1416
[Abstract] [Full Text] -
Barber, D., Miller, G., McNamara, P., Sundberg, P., Vogel, L. P., Blackman, B. T., White, D. G., McDermott, P. F., Meng, J., McDonald, L. C., Sorensen, T. L., Wegener, H. C., Frimodt-Moller, N.
(2002). Resistant Bacteria in Retail Meats and Antimicrobial Use in Animals. NEJM
346: 777-779
[Full Text] -
Bischoff, K. M., White, D. G., McDermott, P. F., Zhao, S., Gaines, S., Maurer, J. J., Nisbet, D. J.
(2002). Characterization of Chloramphenicol Resistance in Beta-Hemolytic Escherichia coli Associated with Diarrhea in Neonatal Swine. J. Clin. Microbiol.
40: 389-394
[Abstract] [Full Text] -
Maniatis, A. N., Pournaras, S., Kanellopoulou, M., Kontos, F., Dimitroulia, E., Papafrangas, E., Tsakris, A.
(2001). Dissemination of Clonally Unrelated Erythromycin- and Glycopeptide-Resistant Enterococcus faecium Isolates in a Tertiary Greek Hospital. J. Clin. Microbiol.
39: 4571-4574
[Abstract] [Full Text] -
Boerlin, P., Wissing, A., Aarestrup, F. M., Frey, J., Nicolet, J.
(2001). Antimicrobial Growth Promoter Ban and Resistance to Macrolides and Vancomycin in Enterococci from Pigs. J. Clin. Microbiol.
39: 4193-4195
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»